Page last updated: 2024-08-25

sofosbuvir and Waldenstrom Macroglobulinemia

sofosbuvir has been researched along with Waldenstrom Macroglobulinemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Dholaria, B; Juskevicius, R; Moreno Vanegas, YA1
Ballestrero, A; Brunacci, M; Crespi, M; Demarzo, MG; Ferrando, F; Giannini, EG; Grillo, F; Pellegatta, G; Savarino, V1

Reviews

1 review(s) available for sofosbuvir and Waldenstrom Macroglobulinemia

ArticleYear
Improvement in Waldenström's Macroglobulinemia after Successful Treatment of HCV with Direct-acting Antivirals.
    Annals of hepatology, 2018, 10-16, Volume: 17, Issue:6

    Topics: Antiviral Agents; Biopsy, Needle; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Immunohistochemistry; Liver Cirrhosis; Middle Aged; Severity of Illness Index; Simeprevir; Sofosbuvir; Treatment Outcome; Waldenstrom Macroglobulinemia

2018

Other Studies

1 other study(ies) available for sofosbuvir and Waldenstrom Macroglobulinemia

ArticleYear
Hepatitis C Virus-associated Lymphoplasmacytic Lymphoma With Waldenström Macroglobulinemia: Response to Direct-acting Antiviral Therapy.
    Clinical lymphoma, myeloma & leukemia, 2020, Volume: 20, Issue:4

    Topics: Benzimidazoles; Fluorenes; Hepacivirus; Hepatitis C; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sofosbuvir; Waldenstrom Macroglobulinemia

2020